South Africa’s Aspen Pharmacare said on Monday that its Canadian subsidiary had received regulatory approval from Health Canada for Aspen-Semaglutide, a generic semaglutide injectable used to treat adults with type 2 diabetes.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
